Delivery Order SPE2DB24D1021-SPE2DB25FFBAD
Award Date 9/22/25
Potential Completion Date 9/23/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $14,424.27 delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg units in quantities of 30. The contract represents a firm fixed-price delivery order with an ultimate completion date of July 18, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The U.S. Defense Department's Medical Supply Chain awarded a firm fixed-price delivery order valued at $3,620.08 to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Emtricitabine-Tenofovir 200-300 mg tablets in quantities of 30. This non-competitive delivery order, which serves military and federal healthcare systems, represents a single transaction under AmerisourceBergen's larger contract vehicle with the Defense Logistics Agency. The pharmaceutical products will be...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Emtricitabine-Tenofovir (200-300mg) in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $3,198.40 and an ultimate completion date of August 22, 2025. The contract was competitively awarded without a set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,785.13 with firm fixed pricing and an ultimate completion date of September 9, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $2,346.16 to AmerisourceBergen Drug Corp for the supply of Emtricitabine-Tenofovir 200-300mg tablets in quantities of 30 units. This non-set-aside, firm fixed-price delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg tablets in units of 30 with a ceiling value of $2,162.91. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a non-competitive award issued under an existing contract vehicle and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg in units of 30s, with a ceiling value of $3,142.77 and a firm fixed price structure. This non-set-aside competitive award is categorized as a delivery order under a larger contract vehicle and represents a single transaction within AmerisourceBergen's extensive pharmaceutical distribution portfolio supporting federal...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 26, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $2,267.03, is scheduled for completion by July 28, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $2,375.23 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg in quantities of 30 units. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a non-competitive procurement under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Emtricitabine-Tenofovir 200-300mg in units of 30 tablets, with a ceiling value of $1,787.67. This competitively awarded, firm fixed price delivery order is scheduled for completion by September 9, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation and represents...